Surgical management of epithelial ovarian cancer: a review of the literature

Abstract

Epithelial ovarian cancer affects over 190,000 women worldwide. Over the past 40 years the median survival rate for women affected with this disease has increased from 12 months to 38 months. While advances in chemotherapy have enhanced our armamentarium, optimal cytoreductive surgery by well trained specialists offers the best opportunity for a long disease free interval.